Applied DNA Sciences (APDN) Misses Q3 EPS by 5c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. SPY
3. FLG
4. GMAB
5. ACCV
6. QQQ
7. TSLA
8. SPCX
9. XNCR
10. AZN

Go back to Applied DNA Sciences (APDN) Misses Q3 EPS by 5c

Applied DNA Reports Fiscal Third Quarter 2020 Financial Results

August 6, 2020 4:05 PM EDT

Company to Hold Conference Call and Webcast Today, Thursday, August 6, 2020, at 4:30 PM EDT

STONY BROOK, N.Y.--(BUSINESS WIRE)-- Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables in vitro diagnostics, pre-clinical nucleic acid-based therapeutic drug candidates, supply chain security, anti-counterfeiting and anti-theft technology, today announced consolidated financial results for the fiscal third quarter and the nine months ended June 30, 2020.

We continued during the quarter to position the Company to serve the unmet and... More